CAS 139481-72-4

Trityl Candesartan

Descrizione:

Trityl Candesartan, con il numero CAS 139481-72-4, è un composto chimico che appartiene alla classe degli antagonisti del recettore dell'angiotensina II, progettato specificamente per il trattamento dell'ipertensione e dell'insufficienza cardiaca. È un pro-farmaco del Candesartan, il che significa che viene convertito nella sua forma attiva nel corpo. La struttura di Trityl Candesartan presenta un gruppo tritilo, che migliora la sua lipofilia e biodisponibilità. Questo composto mostra alta affinità per il recettore dell'angiotensina II, portando a vasodilatazione e a una successiva riduzione della pressione sanguigna. Il suo profilo farmacocinetico include una buona assorbimento e una vita media relativamente lunga, consentendo una somministrazione una volta al giorno. Inoltre, Trityl Candesartan è caratterizzato dalla sua stabilità in condizioni fisiologiche, rendendolo adatto per applicazioni terapeutiche. Come per molti farmaci, è essenziale considerare i potenziali effetti collaterali e controindicazioni, che possono includere vertigini, ipotensione e compromissione renale. In generale, Trityl Candesartan rappresenta un significativo progresso nella terapia antipertensiva.

Formula: C₄₃H₃₄N₆O₃

InChI: InChI=1/C43H34N6O3/c1-2-52-42-44-38-24-14-23-37(41(50)51)39(38)48(42)29-30-25-27-31(28-26-30)35-21-12-13-22-36(35)40-45-46-47-49(40)43(32-15-6-3-7-16-32,33-17-8-4-9-18-33)34-19-10-5-11-20-34/h3-28H,2,29H2,1H3,(H,50,51)

InChI key: InChIKey=VBMKOTRJWPIKMG-UHFFFAOYSA-N

SMILES: C(N1C(=NN=N1)C2=C(C=CC=C2)C3=CC=C(CN4C=5C(N=C4OCC)=CC=CC5C(O)=O)C=C3)(C6=CC=CC=C6)(C7=CC=CC=C7)C8=CC=CC=C8

Sinonimi:

• 1H-benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-
• 2-Ethoxy-1-((2′-(1-trityl-1H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylic acid
• 2-Ethoxy-1-[(2′-(1-trityl-1H-tetrazol-5-yl)-1,1′-biphenyl-4-yl)methyl]-7-benzimidazolecarboxylic acid
• 2-Ethoxy-1-[[2′-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid
• 2-Ethoxy-1-{[2'-(1-trityl-1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylic acid
• 2-Ethoxy-1-{[2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
• 2-ethoxy-1-[[(2'-(1-triphenylmethyl-1h-tetrazol-5-yl)biphenyl-4-yl)methyl]benzimidazole-7-carboxylic acid
• DISCONTINUED
• TritylCandesartan[CandesartabCilexetilIntermediates]
• Candesartan Cilexetil Impurity 9
• 2-Ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-c
• 2-ETHOXY-1-[[(2-(1-TRIPHENYLMETHYL-1H-TETRAZOL-5-YL)BIPHENYL)METHYL] BENZIMIDAZOLE-7-CARBOXYLIC ACID
• 2-ethoxy-3-[[4-[2-[1-(triphenylmethyl)-5-tetrazolyl]phenyl]phenyl]methyl]-4-benzimidazolecarboxylic acid
• (Trityl candesartan)2-Ethoxy-1-[[2-(2-Triphenyl Methyl)-2H-Tetrazole-5-YL](1,1-Biphenyl)-4-YL]Methyl]Benzimidazole-2-Carboxylic Acid
• Triphenyl Candesartan
• Candesartan N1-Trityl IMpurity
• (1H)-Benzimidazole-7-carboxylicacid
• 2-Ethoxy-1-[[(2’-(1-triphenylmethyl-1H-tetrazol-5-yl)biphenyl-4-yl-)methyl]benzimidazole-7-carboxylicacid
• Trityl candesartan/2-Ethoxy-1-[[(2'-(1-triphenylmethyl-1H-tetrazol-5-yl)biphenyl-4-yl)methyl]benzimidazole-7-carboxylic acid
• Candesartan Impurity 8
• TRITYL CANDESARTAN
• TRITYL CANDESARTAN ( FOR CANDESARTAN CILEXETIL )
• Trityl candesartan USP/EP/BP
• Yl][1,1?-Biphenyl]-4-Yl]Methyl]-1H-Benzimidazole-7- Carboxylic Acid [N-Trityl Candesartan]
• N-Trityl Candesartan
• 2-Ethoxy-1-[[2?-[2-(Triphenylmethyl)-2H-Tetrazol-5-
• 2-ethoxy-1-[[(2-(1-triphenylmethyl-1Htetrazol-5-yl)biphenyl-4-yl-)
• CANDESARTAN INTERMEDIATE A
• Intermediate 5
• 2-Ethoxy-1-[[2-(2-Triphenylmethyl)-2H-Tetrazole-5-Yl](1,1-Biphenyl)-4-Yl]-Methyl]Benzimidazole-7-Carboylicacid
• Candesartan Cilexetil
• N-trimethylcandesartan
• Candesartan Cilexetil Impurity 14
• Trityl Candesartan (C9)
• 2-Ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-
• TritylCandesartan,CandesartanCilexetil

Trityl candesartan

CAS: 139481-72-4

Formula: C₄₃H₃₄N₆O₃

Purezza: 97%

Colore e forma: Solid

Peso molecolare: 682.7685

Ref: IN-DA007Z8Q

2-Ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylic acid

CAS: 139481-72-4

2-Ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylic acid

Purezza: 97%

Peso molecolare: 682.78g/mol

Ref: 54-OR1068771

N-Trityl Candesartan

CAS: 139481-72-4

Formula: C₄₃H₃₄N₆O₃

Colore e forma: White To Off-White Solid

Peso molecolare: 682.79

Ref: 4Z-C-0113

Trityl candesartan

CAS: 139481-72-4

Trityl candesartan is a crucial intermediate used in the synthesis of Candesartan and Candesartan cilexetil, which are angiotensin II receptor antagonists.

Formula: C₄₃H₃₄N₆O₃

Purezza: 98.97%

Colore e forma: Solid

Peso molecolare: 682.77

Ref: TM-T65740

N-Trityl Candesartan

CAS: 139481-72-4

Formula: C₄₃H₃₄N₆O₃

Peso molecolare: 682.77

Ref: ST-EA-CP-C50018

N-Trityl candesartan

CAS: 139481-72-4

N-Trityl candesartan is a benzimidazole derivative. It is a prodrug that is activated by esterases to the active form, candesartan. Candesartan has been shown to be effective in the treatment of high blood pressure when combined with cilexetil, but not when used alone. The regression analysis data showed that N-trityl candesartan was more potent than candesartan in lowering blood pressure in rats. This analog also had improved uptake and metabolism compared to its parent compound.

Formula: C₄₃H₃₄N₆O₃

Purezza: Min. 95%

Peso molecolare: 682.77 g/mol

Ref: 3D-FT28595